Probo Medical Signs Definitive Purchase Agreement to Acquire Alpha Source Group
Alpha Source, founded in 1986, delivers technical field service, depot repair, equipment refurbishment and resale, and parts distribution solutions to the North American healthcare market. Their expertise and capabilities are utilized across a broad customer base that includes OEMs, ISOs, asset managers, hospitals, distributors and resellers. With more than 100 field-based engineers, Alpha Source is one of the largest field service organizations for diagnostic imaging equipment in
"This acquisition is transformational in nature for both Probo Medical and Alpha Source," said
Probo Medical is backed by Avista Capital Partners, a leading private equity firm focused exclusively on healthcare with over
About Probo Medical
Probo Medical is a global diversified supplier of new and refurbished diagnostic imaging equipment sales, service, rental, repair and installation of a vast array of imaging equipment, including ultrasound, c-arm, x-ray, mammography, fluoroscopy, MRI and CT. For more information about Probo Medical, visit http://www.probomedical.com.
About Alpha Source Group
Alpha Source, founded in 1986 and headquartered in
Contact:
Email: [email protected]
View original content:https://www.prnewswire.com/news-releases/probo-medical-signs-definitive-purchase-agreement-to-acquire-alpha-source-group-302022973.html
SOURCE Probo Medical
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Getty Images in talks with lenders on rescue financing - report
- RTX's Raytheon awarded $20.7 billion multi-year contract for AMRAAM under landmark production agreement
- Extension of the Managing Directors' employment contracts of Carsten Cramer, Lars Ricken and Thomas Treß - Carsten Cramer appointed Chairman of the Management Board
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share